Genetic Toxicology Testing Market Growth Outlook Through 2024-2033

Overview and Scope
Genetic toxicology testing is a branch of toxicology that focuses on assessing the potential of chemical substances to cause damage to genetic material, such as DNA, RNA, or chromosomes. The purpose of genetic toxicology testing is to evaluate the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. It is also a critical tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants from genotoxic hazards.

Sizing and Forecast
The genetic toxicology testing market size has grown rapidly in recent years. It will grow from $1.48 billion in 2023 to $1.63 billion in 2024 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rising public health crises, increasing globalization, increased focus on personalized medicine, rising demand for rigorous testing solutions, and an increasing number of drugs.

The genetic toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $2.4 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising demand for testing novel foods, rising concerns about potential risks, rising environmental and health concerns, increasing regulatory scrutiny, increasing use of in vitro testing methods, and the rise of high-throughput screening platforms. Major trends in the forecast period include advances in precision medicine and toxicogenomics, comprehensive risk communication, genetic toxicology testing methodologies, advancing risk assessment methodologies, integration of omics technologies, and advancements in genomics and molecular biology.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Segmentation & Regional Insights
The genetic toxicology testing market covered in this report is segmented –

1) By Type: In Vitro, In Vivo
2) By Product: Services, Reagents And Consumables, Assays
3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications

North America was the largest region in the genetic toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=15574&type=smp

Major Driver Impacting Market Growth
The increasing demand for personalized medicine is expected to propel the growth of the genetic toxicology testing market going forward. Personalized medicine is a medical model that tailors healthcare decisions, practices, interventions, and products to the individual patient based on their predicted response or disease risk. The personalized medicine market has experienced a positive wave due to genetic breakthroughs, increased understanding of diseases, the availability of biomarker-based diagnostics, value-based healthcare initiatives, and integration into clinical practice and research. Genetic toxicology testing contributes to personalized medicine by providing essential information about genetic variability, susceptibility to genotoxic agents, and treatment response. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized medicines for rare disease patients, a rise from six in 2022. Therefore, the increasing demand for personalized medicine drives the genetic toxicology testing market.

Key Industry Players

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

The genetic toxicology testing market report table of contents includes:

1. Executive Summary
2. Genetic Toxicology Testing Market Characteristics
3. Genetic Toxicology Testing Market Trends And Strategies
4. Genetic Toxicology Testing Market – Macro Economic Scenario
5. Global Genetic Toxicology Testing Market Size and Growth
.
.
.
31. Genetic Toxicology Testing Market Other Major And Innovative Companies
32. Global Genetic Toxicology Testing Market Competitive Benchmarking
33. Global Genetic Toxicology Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Genetic Toxicology Testing Market
35. Genetic Toxicology Testing Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model